These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37673886)

  • 1. Comprehensive analyses of fatty acid metabolism-related lncRNA for ovarian cancer patients.
    Li M; Yan Y; Liu Y; Zhao J; Guo F; Chen J; Nie L; Zhang Y; Wang Y
    Sci Rep; 2023 Sep; 13(1):14675. PubMed ID: 37673886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
    Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
    J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer.
    Wang J; Zhang X; Zheng F; Yang Q; Bi F
    J Ovarian Res; 2023 Aug; 16(1):177. PubMed ID: 37633972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma.
    Wang H; Cui J; Yu J; Huang J; Li M
    Front Genet; 2022; 13():855940. PubMed ID: 35464865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer.
    Zheng J; Jiang S; Lin X; Wang H; Liu L; Cai X; Sun Y
    BMC Womens Health; 2024 Jan; 24(1):37. PubMed ID: 38218807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.
    Jin X; Chen Y; Hu Q
    Sci Rep; 2024 Mar; 14(1):7593. PubMed ID: 38556590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer.
    Feng J; Yu Y; Yin W; Qian S
    J Ovarian Res; 2023 Feb; 16(1):31. PubMed ID: 36739404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs.
    Li X; Liu H; Wang F; Yuan J; Guan W; Xu G
    Curr Med Chem; 2024; 31(26):4213-4231. PubMed ID: 38357948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer.
    Wu W; Gao C; Chen L; Zhang D; Guo S
    Oncol Lett; 2021 Dec; 22(6):843. PubMed ID: 34777587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients.
    Zheng J; Guo J; Zhu L; Zhou Y; Tong J
    J Ovarian Res; 2021 Sep; 14(1):124. PubMed ID: 34560889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
    Peng J; Hao Y; Rao B; Zhang Z
    Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer.
    Wang K; Mei S; Cai M; Zhai D; Zhang D; Yu J; Ni Z; Yu C
    Front Oncol; 2022; 12():888699. PubMed ID: 35756659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X; Ye Z; Xiao G; He T
    Comput Biol Med; 2023 Jun; 159():106905. PubMed ID: 37060773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
    Zheng J; Guo J; Cao B; Zhou Y; Tong J
    Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
    Front Oncol; 2022; 12():833763. PubMed ID: 35280814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.